[Prognostic significance of early molecular response after second-line treatment with dasatinib of chronic myeloid leukemia patients]
[达沙替尼二线治疗慢性粒细胞白血病患者后早期分子反应的预后意义]
期刊:Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
影响因子:
doi:10.3760/cma.j.issn.0253-2727.2019.07.015
Chen, Y L; Meng, L; Yan, G L; Yang, Z Z; Huang, Z P; Zhang, Y S; Zhao, Z; Wang, C C; Bao, Y; Xiang, H; Yin, H; Chen, L F; Xiong, Y Y; Wang, L; Li, W M